NCT06648057 2026-03-18
Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab
CHA University
Recruiting
CHA University
German Cancer Research Center
Shanghai Proton and Heavy Ion Center
German Cancer Research Center
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Australian & New Zealand Children's Haematology/Oncology Group
Vall d'Hebron Institute of Oncology